Fluid balance-adjusted creatinine at initiation of continuous venovenous hemofiltration and mortality. A post-hoc analysis of a multicenter randomized controlled trial.
- Stads, S. (Susanne)
- Schilder, L. (Louise)
- Azam Nurmohamed, S. (S.)
- Bosch, F.H. (Frank)
- Purmer, I.M. (Ilse M.)
- den Boer, S.S. (Sylvia S.)
- Kleppe, C.G. (Cynthia G.)
- Vervloet, M.G. (Marc)
- Beishuizen, A. (Albertus)
- Girbes, A.R.J. (Armand)
- Wee, P.M. (Piet) ter
- Gommers, D.A.M.P.J. (Diederik)
- Groeneveld, A.B.J. (Johan)
- Oudemans-van Straaten, H.M. (Heleen)
Publication date
June 2018
DOIAbstract
Introduction Acute kidney injury (AKI) requiring renal replacement therapy (RRT) is associated with high mortality. The creatinine-based stage of AKI is considered when deciding to start or delay RRT. However, creatinine is not only determined by renal function (excretion), but also by dilution (fluid balance) and creatinine generation (muscle mass). The aim of this study was to explore whether fluid balance-adjusted creatinine at initiation of RRT is rel
Add to ORKG